首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Pneumococcal Serotypes Causing Pneumonia with Pleural Effusion in Pediatric Patients
【2h】

Pneumococcal Serotypes Causing Pneumonia with Pleural Effusion in Pediatric Patients

机译:小儿肺炎球菌血清型引起肺炎伴胸腔积液

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

To determine the prevalence of serotypes of Streptococcus pneumoniae responsible for pneumonia with pleural effusion, we determined the capsular polysaccharide (PS) type directly on 49 pleural fluid specimens collected from pediatric patients during 2007 to 2009 with laboratory-confirmed pneumococcal pneumonia by using monoclonal antibodies and a multiplex, bead array immunoassay. Because the fluids had to be heated to remove nonspecific reactivity before being tested in the immunoassay and type 19A PS is heat labile, the pleural fluid samples were also tested for serotype 19A capsule gene locus by PCR. Use of the multiplex immunoassay combined with type-specific 19A PCR allowed for serotype determination on 40 of 49 pleural fluids. Pneumococcal pneumonia with pleural effusion was associated with a limited number of serotypes, with types 1, 3, 7F/A, and 19A accounting for 75% of the typeable cases. The concentration of capsular PS in the pleural fluids was often greater than 1 μg/ml and sufficient to inhibit the opsonic capacity of sera from individuals who had received the 23-valent pneumococcal PS vaccine. Based on the serotypes observed before and after introduction of the 7-valent pneumococcal conjugate vaccine, the recently licensed 13-valent pneumococcal conjugate vaccine may reduce the incidence of pneumonia with pleural effusions.
机译:为了确定引起胸膜积液性肺炎的肺炎链球菌血清型的患病率,我们使用单克隆抗体和多重珠阵列免疫测定。由于必须先对液体进行加热以去除非特异性反应性,然后再进行免疫测定,并且19A PS型不耐热,因此还通过PCR对胸膜液样品中的血清型19A胶囊基因位点进行了测试。将多重免疫测定与19A型特异性PCR结合使用,可以对49种胸膜液中的40种进行血清型测定。肺炎球菌性肺炎伴胸腔积液与有限的血清型有关,其中1、3、7F / A和19A型占可分型病例的75%。胸膜积液中荚膜PS的浓度通常大于1μg/ ml,足以抑制接受23价肺炎球菌PS疫苗的个体的血清调理能力。基于在引入7价肺炎球菌结合疫苗之前和之后观察到的血清型,最近获得许可的13价肺炎球菌结合疫苗可以降低胸膜积液引起的肺炎的发病率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号